ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,182, issued on Sept. 22, was assigned to VLP Therapeutics Inc. (Wilmington, Del.).
"Cytokine immunotherapy" was invented by Wataru Akahata (Kensington, Md.) and Jonathan F. Smith (Redwood City, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein is a novel immunologically-active alphavirus replicon vector which comprises a nucleic acid encoding alphavirus nonstructural proteins nsp1-4 and a cytokine protein(s)/polypeptide(s), which is useful for the treatment of a cancer and/or an inflammatory disease."
The patent was filed on Aug. 19, 2024, under Application No. 18/809,221.
*For further information, including images, charts and...